Search
Search
Diana V. Do, MD, and Glenn J. Jaffe, MD
Show Description +
Diana V. Do, MD, and Glenn J. Jaffe, MD, discuss the efficacy and safety outcomes from the LIGHTSITE III clinical trial evaluating the Valeda® Light Delivery System for the treatment of dry age-related macular degeneration (AMD). Dr. Do shares key results from the study, emphasizing how the trial successfully met its primary visual acuity endpoints. Valeda® Light Delivery System is FDA-Authorized, CE-Marked, UKCA-Marked, and commercially available in select countries across Latin America.
Posted: 4/29/2025
Diana V. Do, MD, and Glenn J. Jaffe, MD
Diana V. Do, MD, and Glenn J. Jaffe, MD, discuss the efficacy and safety outcomes from the LIGHTSITE III clinical trial evaluating the Valeda® Light Delivery System for the treatment of dry age-related macular degeneration (AMD). Dr. Do shares key results from the study, emphasizing how the trial successfully met its primary visual acuity endpoints. Valeda® Light Delivery System is FDA-Authorized, CE-Marked, UKCA-Marked, and commercially available in select countries across Latin America.
Posted: 4/29/2025
About LumiThera
Visit Us Online: lumithera.com
Follow LumiThera
© 2025 LumiThera, Inc. www.lumithera.com
MKT-0039 REV A
Valeda is CE Marked in the EU.
FDA-Authorized
